help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, J. L.
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, J. L.
Right arrow Articles by Baxter, R. C.

Endocrinology, Vol 131, 1703-1710, Copyright © 1992 by Endocrine Society


ARTICLES

Insulin-like growth factor-I (IGF-I) and transforming growth factor- beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms

JL Martin, M Ballesteros and RC Baxter
Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Human neonatal fibroblasts in monolayer culture secrete insulin-like growth factor-binding proteins (IGFBPs), which may modulate IGF action. To examine whether an increase in extracellular concentrations of IGFBPs in response to IGF-I is due to the release of cell-associated IGFBPs, we measured secreted and cell-associated IGFBP-3 immunologically in fibroblast monolayers treated with IGF-I and IGF analogs with altered affinities for the IGF receptors and IGFBPs. IGFBP- 3 in medium conditioned by fibroblasts treated with IGF-I was significantly increased (P < 0.05) compared with that in medium from untreated cultures; concomitantly, cell-associated IGFBP-3 was significantly decreased (P < 0.05). [Ser24]IGF-I (reduced affinity for IGF receptors) also increased secreted IGFBP-3 and decreased cell- associated IGFBP-3. In contrast, IGFBP-3 concentrations in medium conditioned by fibroblasts treated with B-chain IGF-I (reduced affinity for IGFBPs) were not significantly increased, and cell-associated IGFBP- 3 was unchanged. Heparin, which releases proteins attached to cell surface proteoglycans, increased medium concentrations of IGFBP-3 and decreased IGFBP-3 binding to fibroblasts. An IGFBP of 29-31 kilodaltons (kDa) showed a pattern of regulation similar to that of IGFBP-3, while a third IGFBP, of 24 kDa, was decreased in IGF-I- and [Ser24]IGF-I- conditioned medium and unchanged by B-chain IGF-I and heparin. Preincubation with transforming growth factor-beta 1 (TGF beta 1), which stimulates fibroblast IGFBP-3 production, or human serum-derived IGFBP-3 did not increase cell-associated IGFBP-3. Analysis of total RNA isolated from fibroblasts revealed that IGFBP-3 mRNA was increased by TGF beta 1, but not by IGF-I. These data suggest that IGFs and TGF beta 1 release fibroblast IGFBPs by distinct mechanisms: IGFs by binding and subsequent release of cell-associated IGFBP-3 and 29- to 31-kDa IGFBP, and TGF beta 1 by increased de novo synthesis of IGFBP-3.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. Jogie-Brahim, D. Feldman, and Y. Oh
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Endocr. Rev., August 1, 2009; 30(5): 417 - 437.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Martin and S. Jambazov
Insulin-Like Growth Factor Binding Protein-3 in Extracellular Matrix Stimulates Adhesion of Breast Epithelial Cells and Activation of p44/42 Mitogen-Activated Protein Kinase
Endocrinology, September 1, 2006; 147(9): 4400 - 4409.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. Peters, I. Tossidou, J. Achenbach, R. Woroniecki, M. Mengel, J.-K. Park, M. Paschy, K. de Groot, H. Haller, and M. Schiffer
IGF-Binding Protein-3 Modulates TGF-beta/BMP-Signaling in Glomerular Podocytes
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1644 - 1656.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Izumi, D. Kurosaka, T. Iwata, Y. Oguchi, Y. Tanaka, Y. Mashima, and K. Tsubota
Involvement of Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Corneal Fibroblasts during Corneal Wound Healing
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. F. Lu, X. G. Jiang, Y. B. Lu, J. H. Bai, and Z. B. Mao
Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells
J. Biol. Chem., June 17, 2005; 280(24): 22606 - 22615.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Beattie, K. Phillips, J. H Shand, M. Szymanowska, D. J Flint, and G. J Allan
Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis
J. Mol. Endocrinol., February 1, 2005; 34(1): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-W. Lee, B. Liu, L. Ma, H. Li, P. Bang, H. P. Koeffler, and P. Cohen
Cellular Internalization of Insulin-like Growth Factor Binding Protein-3: DISTINCT ENDOCYTIC PATHWAYS FACILITATE RE-UPTAKE AND NUCLEAR LOCALIZATION
J. Biol. Chem., January 2, 2004; 279(1): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Martin, S. M. Weenink, and R. C. Baxter
Insulin-like Growth Factor-binding Protein-3 Potentiates Epidermal Growth Factor Action in MCF-10A Mammary Epithelial Cells. INVOLVEMENT OF p44/42 AND p38 MITOGEN-ACTIVATED PROTEIN KINASES
J. Biol. Chem., January 24, 2003; 278(5): 2969 - 2976.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev., December 1, 2002; 23(6): 824 - 854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. G. Simmons, J. B. Pucilowska, T. O. Keku, and P. K. Lund
IGF-I and TGF-beta 1 have distinct effects on phenotype and proliferation of intestinal fibroblasts
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G809 - G818.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Butt, K. A. Fraley, S. M. Firth, and R. C. Baxter
IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation in Human Breast Cancer Cells
Endocrinology, July 1, 2002; 143(7): 2693 - 2699.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Firth, F. MCDougall, A. J. MCLachlan, and R. C. Baxter
Impaired Blockade of Insulin-Like Growth Factor I (IGF-I)-Induced Hypoglycemia by IGF Binding Protein-3 Analog with Reduced Ternary Complex-Forming Ability
Endocrinology, May 1, 2002; 143(5): 1669 - 1676.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
R. Rajah, K.-W. Lee, and P. Cohen
Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation
Cell Growth Differ., April 1, 2002; 13(4): 163 - 171.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. R. Clemmons
Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships
Endocr. Rev., December 1, 2001; 22(6): 800 - 817.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Twigg, M. M. Chen, A. H. Joly, S. D. Chakrapani, J. Tsubaki, H.-S. Kim, Y. Oh, and R. G. Rosenfeld
Advanced Glycosylation End Products Up-Regulate Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein-Related Protein 2) in Human Fibroblasts: A Potential Mechanism for Expansion of Extracellular Matrix in Diabetes Mellitus
Endocrinology, May 1, 2001; 142(5): 1760 - 1769.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. L. Martin and S. L. Pattison
Insulin-Like Growth Factor Binding Protein-3 Is Regulated by Dihydrotestosterone and Stimulates Deoxyribonucleic Acid Synthesis and Cell Proliferation in LNCaP Prostate Carcinoma Cells
Endocrinology, July 1, 2000; 141(7): 2401 - 2409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Cohen, R. Rajah, J. Rosenbloom, and D. J. Herrick
IGFBP-3 mediates TGF-beta 1-induced cell growth in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L545 - L551.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Coverley, J. L. Martin, and R. C. Baxter
The Effect of Phosphorylation by Casein Kinase 2 on the Activity of Insulin-Like Growth Factor-Binding Protein-3
Endocrinology, February 1, 2000; 141(2): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Bruyninx, B. Hennuy, A. Cornet, P. Houssa, M. Daukandt, E. Reiter, J. Poncin, J. Closset, and G. Hennen
A Novel Gene Overexpressed in the Prostate of Castrated Rats: Hormonal Regulation, Relationship to Apoptosis and to Acquired Prostatic Cell Androgen Independence
Endocrinology, October 1, 1999; 140(10): 4789 - 4799.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. L. Martin and R. C. Baxter
Oncogenic ras Causes Resistance to the Growth Inhibitor Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in Breast Cancer Cells
J. Biol. Chem., June 4, 1999; 274(23): 16407 - 16411.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Yamanaka, J. L. Fowlkes, E. M. Wilson, R. G. Rosenfeld, and Y. Oh
Characterization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Binding to Human Breast Cancer Cells: Kinetics of IGFBP-3 Binding and Identification of Receptor Binding Domain on the IGFBP-3 Molecule
Endocrinology, March 1, 1999; 140(3): 1319 - 1328.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Olivecrona, A. Hilding, C. Ekström, H. Barle, B. Nyberg, C. Möller, P. J. Delhanty, R. C. Baxter, B. Angelin, T. J. Ekström, et al.
Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 553 - 560.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. A. Price
Peptide Growth Factors Regulate Insulin-Like Growth Factor Binding Protein Production by Fetal Rat Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 332 - 341.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. J. Schedlich, T. F. Young, S. M. Firth, and R. C. Baxter
Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells
J. Biol. Chem., July 17, 1998; 273(29): 18347 - 18352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Huang and J. S. Huang
A Pentacosapeptide (CKS-25) Homologous to Retroviral Envelope Proteins Possesses a Transforming Growth Factor-beta Activity
J. Biol. Chem., February 27, 1998; 273(9): 4815 - 4818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Firth, U. Ganeshprasad, and R. C. Baxter
Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3
J. Biol. Chem., January 30, 1998; 273(5): 2631 - 2638.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. C. Russo, L. A. Bach, A. J. Fosang, N. L. Baker, and G. A. Werther
Insulin-Like Growth Factor Binding Protein-2 Binds to Cell Surface Proteoglycans in the Rat Brain Olfactory Bulb
Endocrinology, November 1, 1997; 138(11): 4858 - 4867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Leal, Q. Liu, S. S. Huang, and J. S. Huang
The Type V Transforming Growth Factor beta  Receptor Is the Putative Insulin-like Growth Factor-binding Protein 3 Receptor
J. Biol. Chem., August 15, 1997; 272(33): 20572 - 20576.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. Rechler
Editorial: Growth Inhibition by Insulin-Like Growth Factor (IGF) Binding Protein-3--What's IGF Got To Do with It?
Endocrinology, July 1, 1997; 138(7): 2645 - 2647.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Rajah, B. Valentinis, and P. Cohen
Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-beta 1 on Programmed Cell Death through a p53- and IGF-independent Mechanism
J. Biol. Chem., May 2, 1997; 272(18): 12181 - 12188.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Salahifar, R. C. Baxter, and J. L. Martin
Insulin-like Growth Factor Binding Protein (IGFBP)-3 Protease Activity Secreted by MCF-7 Breast Cancer Cells: Inhibition by IGFs Does Not Require IGF-IGFBP Interaction
Endocrinology, April 1, 1997; 138(4): 1683 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. C. Villafuerte, W. Zhao, A. C. Herington, R. Saffery, and L. S. Phillips
Identification of an Insulin-responsive Element in the Rat Insulin-like Growth Factor-binding Protein-3 Gene
J. Biol. Chem., February 21, 1997; 272(8): 5024 - 5030.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Fowlkes and D. M. Serra
Characterization of Glycosaminoglycan-binding Domains Present in Insulin-like Growth Factor-binding Protein-3
J. Biol. Chem., June 21, 1996; 271(25): 14676 - 14679.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Arai, J. Clarke, A. Parker, W. Busby Jr., T. Nam, and D. R. Clemmons
Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin
J. Biol. Chem., March 15, 1996; 271(11): 6099 - 6106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Huynh, X. Yang, and M. Pollak
Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer Cells
J. Biol. Chem., January 12, 1996; 271(2): 1016 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Oh, H. L. Müller, L. Ng, and R. G. Rosenfeld
Transforming Growth Factor- [IMAGE]-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action
J. Biol. Chem., June 9, 1995; 270(23): 13589 - 13592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. J. Schedlich, S. L. Le Page, S. M. Firth, L. J. Briggs, D. A. Jans, and R. C. Baxter
Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin beta Subunit
J. Biol. Chem., July 28, 2000; 275(31): 23462 - 23470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Butt, S. M. Firth, M. A. King, and R. C. Baxter
Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells
J. Biol. Chem., December 8, 2000; 275(50): 39174 - 39181.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society